The Application of an Innovative Reactive Agility Testing System for Assessment in Older Adults W… (NCT07375888) | Clinical Trial Compass
CompletedNot Applicable
The Application of an Innovative Reactive Agility Testing System for Assessment in Older Adults With Dynapenia
Taiwan104 participantsStarted 2025-11-24
Plain-language summary
Before the experiment, the researchers explain the purpose and procedures to the participants. After signing the informed consent form and completing basic personal information, participants perform a 5-minute warm-up. They then practice the test procedure 1-3 times to become familiar with the visual stimuli, followed by a 3-minute rest before the formal experiment.
Body composition and physical performance are assessed using handgrip strength, the five-time sit-to-stand test, and the skeletal muscle mass index.
Fall risk is evaluated using a localized fall risk awareness questionnaire.
Agility is tested using a reaction-based running task. Participants stand in a 1 m × 1 m preparation area, and one of two sensor lights placed 3 meters away lights up randomly. Participants run forward, pass through a photo gate, and touch the light to turn it off. Decision time, movement time, and total time are recorded over 10 trials.
Who can participate
Age range
65 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Community-dwelling older adults aged 65 years and above
* Able to communicate with the researchers through spoken or written language
* Able to cooperate with all required assessments
Exclusion Criteria:
* Individuals with cognitive impairment
* Individuals who experience chest pain during recent exercise
* Individuals with angina or joint pain
* Individuals with congestive heart failure
* Individuals who have been advised by a physician not to exercise
* Patients with cancer currently receiving chemotherapy or radiotherapy
* Individuals with neuromuscular disorders or musculoskeletal injuries involving the ankle, knee, or hip joints
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Decision time
Timeframe: From participant enrollment to the end of testing
2
movement time
Timeframe: From participant enrollment to the end of testing